Geopolitical Strains Escalate as Ukrainian Drone Incidents Rattle NATOs Eastern Borders Jim Cramers Take on NVIDIA Ahead of Earnings Key Insights and Market Reactions Intel Pushes PC Makers to Adopt 18A Chips as AI Demand Fuels Semiconductor Growth UK Seals Historic Trade Deal with Gulf States Poised to Boost Economy by Billions Japans Megabanks Hit Record Profits but Analysts Flag Rising Risks and Potential Slowdown Market Update ZBH BUD and VTRS Show Mixed Trends Amid Sector Rotation XPON Q2 2025 Earnings EPS Beats Estimates Despite Revenue Absence Federal Realty Investment Trust FRT Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance FRSX Q3 2021 Earnings NarrowerThanExpected Loss Drives Positive Market Response RVTY Q1 2026 Earnings EPS Surpasses Estimates Amid Flat Stock Reaction VZ Q1 2026 Earnings EPS Beats Estimates by Nearly 4 as Wireless Business Holds Steady Karooooo Ltd KARO Q1 2026 Earnings EPS Misses by 196 Yet Stock Gains 23 TDS Shares Decline Sharply as Selling Pressure Intensifies Eaton Vance Municipal Income 2028 Term Trust ETX Shows Modest Uptick Amid Steady Trading Eaton Vance Diversified Equity Income Fund ETY Slightly Lower as IncomeFocused Investors Weigh Rate Outlook Driven Brands DRVN Jumps 3 as Stock Holds Key Support Zone Haymaker Acquisition Corp 4 HYAC Edges Higher Above 1075 as SPAC Gains Momentum eHealth EHTH Receives Price Target Increase Amid Operational Improvements Argan Inc AGX Q1 2026 Earnings EPS Surges 737 Above Estimates Shares Climb Nearly 2 Pitney Bowes Faces Resistance as Selling Pressure Intensifies Community Financial System Inc CBU Edges Higher Near Support as Uptrend Remains Intact ReposiTrak Inc TRAK Edges Higher Navigating Resistance at 1062 Amid Steady Volume VisionWave VWAVW Extends Bull Run with Another 190 Climb 20260527 Cohen Steers Select Preferred and Income Fund PSF Edges Higher Amid Steady Trading CVB Financial CVBF Holds Steady Near 2035 as Support and Resistance Levels Come into Focus MannKind Corporation MNKD Surges 44 Testing Key Resistance Amid Biotech Momentum Acumen Pharmaceuticals ABOS Gains Nearly 5 as Stock Tests Resistance at 267